Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule
Top Cited Papers
- 11 May 2010
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 24 (9), 3438-3450
- https://doi.org/10.1096/fj.10-154765
Abstract
Klotho has profound effects on phosphate metabolism, but the mechanisms of how Klotho affects phosphate homeostasis is unknown. We detected Klotho in the proximal tubule cell, brush border, and urinary lumen, where phosphate homeostasis resides. Increasing Klotho in the kidney and urine chronically by transgenic overexpression or acutely by intravenous infusion caused hypophosphatemia, phosphaturia from decreased proximal phosphate reabsorption, and decreased activity and protein of the principal renal phosphate transporter NaPi-2a. The phosphaturic effect was present in FGF23-null mice, indicating a direct action distinct from Klotho's known role as a coreceptor for FGF23. Direct inhibition of NaPi-2a by Klotho was confirmed in cultured cells and in cell-free membrane vesicles characterized by acute inhibition of transport activity followed by decreased cell surface protein. Transport inhibition can be mimicked by recombinant beta-glucuronidase and is associated with proteolytic degradation and reduced surface NaPi-2a. The inhibitory effect of Klotho on NaPi-2a was blocked by beta-glucuronidase inhibitor but not by protease inhibitor. Klotho is a novel phosphaturic substance that acts as an enzyme in the proximal tubule urinary lumen by modifying glycans, which cause decreased transporter activity, followed by proteolytic degradation and possibly internalization of NaPi-2a from the apical membrane.Keywords
Funding Information
- Simmons Family Foundation
- National Institutes of Health (AG19712, AG25326, DK067158, DK41612, DK‐48482, DK‐20543, P30‐DK‐079328)
- American Heart Association (0865235F)
- Eisai
- Ellison Medical Foundation
This publication has 72 references indexed in Scilit:
- Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formationProceedings of the National Academy of Sciences of the United States of America, 2009
- Regulation of Renal Outer Medullary Potassium Channel and Renal K+Excretion by KlothoMolecular Pharmacology, 2009
- In vivo genetic evidence for klotho‐dependent, fibroblast growth factor 23 (Fgf23) ‐mediated regulation of systemic phosphate homeostasisThe FASEB Journal, 2008
- Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1Proceedings of the National Academy of Sciences of the United States of America, 2008
- A translocation causing increased α-Klotho level results in hypophosphatemic rickets and hyperparathyroidismProceedings of the National Academy of Sciences of the United States of America, 2008
- Premature aging in klotho mutant mice: Cause or consequence?Ageing Research Reviews, 2007
- Klotho converts canonical FGF receptor into a specific receptor for FGF23Nature, 2006
- Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF‐β/BMP pathwayBritish Journal of Haematology, 2006
- Suppression of Aging in Mice by the Hormone KlothoScience, 2005
- Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs)Kidney International, 2005